Two Dundee University mathematicians have been awarded ?160,000 by the Engineering and Physical Sciences Research Council to develop a new breed of "targeted" anti-cancer drugs. Fordyce Davidson and Mark Chaplain will work with biotechnology company Cyclacel Pharmaceuticals Inc.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to 罢贬贰’蝉 university and college rankings analysis
Already registered or a current subscriber?
Please or to read this article.